7th Gene Therapy Analytical Development Summit Europe

The 7th Gene Therapy Analytical Development Summit Europe returns to London in May 2026 as the leading forum uniting 60+ senior experts from biotech, pharma, and regulatory authorities to advance analytical rigour across gene therapy pipelines. With programmes rapidly progressing into late‑stage development and regulatory review, the summit delivers peer‑led insights on strengthening analytical strategy, QC, and potency assurance to meet evolving EMA expectations. Attendees will hear from innovators including Complement Therapeutics, MeiraGTx, PureSpring Therapeutics, Orchard Therapeutics, UCB and the MHRA, as they share practical solutions for comparability, potency assay development, and analytical readiness. This is your opportunity to connect with empowering teams to accelerate safe, consistent gene therapies from clinic to market.

Find out more here